durapatite has been researched along with olanzapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Cheng, C; Lin, FH; Shyong, YJ; Tseng, HC; Wang, MH | 1 |
| Chang, KC; Kuo, LW; Kuo, WT; Lin, FH; Shyong, YJ; Su, CF; Wang, MH | 1 |
2 other study(ies) available for durapatite and olanzapine
| Article | Year |
|---|---|
Mesoporous Hydroxyapatite as Olanzapine Carrier Provides a Long-Acting Effect in Antidepression Treatment.
Topics: 3T3 Cells; Animals; Antidepressive Agents; Benzodiazepines; Drug Carriers; Durapatite; Humans; Macrophages; Mice; Olanzapine; Porosity; Rats, Wistar | 2015 |
Mesoporous hydroxyapatite as a carrier of olanzapine for long-acting antidepression treatment in rats with induced depression.
Topics: Animals; Behavior, Animal; Benzodiazepines; Brain; Depression; Drug Carriers; Drug Liberation; Durapatite; Locomotion; Male; Maze Learning; Olanzapine; Porosity; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin | 2017 |